AGIO Agios Pharm

$38.80

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Agios Pharm

Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.

Website: https://www.agios.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1439222
Address
88 SIDNEY STREET, CAMBRIDGE, MA, US
Valuation
Market Cap
$1.58B
P/E Ratio
2.38
PEG Ratio
0.00
Price to Book
1.03
Performance
EPS
$11.64
Dividend Yield
—
Profit Margin
1846.00%
ROE
57.30%
Technicals
50D MA
$31.23
200D MA
$41.04
52W High
$62.58
52W Low
$23.41
Fundamentals
Shares Outstanding
57M
Target Price
$53.32
Beta
0.83

AGIO EPS Estimates vs Actual

● Estimated
● Actual

AGIO News & Sentiment

Aug 01, 2025 • Motley Fool SOMEWHAT-BULLISH
Agios ( AGIO ) Q2 Revenue Jumps 45%
Agios Pharmaceuticals ( NASDAQ:AGIO ) , a biotechnology company focused on therapies for rare blood disorders, released its second quarter 2025 earnings on July 31, 2025. The headline was a notable revenue beat: This quarter showcased clear progress on sales for its lead product PYRUKYND, with ...
Jul 31, 2025 • Zacks Commentary NEUTRAL
Agios Pharmaceuticals ( AGIO ) Reports Q2 Loss, Beats Revenue Estimates
Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of -10.92% and +34.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 31, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Agios Reports Second Quarter 2025 Financial Results and Provides Business Update
Agios Pharmaceuticals today announced financial results and updates for the second quarter ended June 30, 2025.
Jul 14, 2025 • Benzinga NEUTRAL
Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET - Agios Pharmaceuticals ( NASDAQ:AGIO )
CAMBRIDGE, Mass., July 14, 2025 ( GLOBE NEWSWIRE ) -- Agios Pharmaceuticals, Inc. AGIO, a leader in cellular metabolism and pyruvate kinase ( PK ) activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, July 31, ...
Jul 14, 2025 • GlobeNewswire NEUTRAL
Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET
Agios Pharmaceuticals announced it will host a conference call and live webcast on Thursday, July 31, 2025, at 8:00 a.m. ET to report its 2Q results ...
Jul 10, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Agios Pharmaceuticals ( AGIO ) Moves 7.7% Higher: Will This Strength Last?
Agios Pharmaceuticals (AGIO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sentiment Snapshot

Average Sentiment Score:

0.039
50 articles with scored sentiment

Overall Sentiment:

Neutral

AGIO Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
0.21 Surprise
  • Reported EPS: $-1.55
  • Estimate: $-1.76
  • Whisper: —
  • Surprise %: 11.9%
Feb 13, 2025
Dec 31, 2024 (Pre market)
-0.11 Surprise
  • Reported EPS: $-1.74
  • Estimate: $-1.63
  • Whisper: —
  • Surprise %: -6.8%
Oct 31, 2024
Sep 30, 2024 (Pre market)
-3.53 Surprise
  • Reported EPS: $-2.42
  • Estimate: $1.11
  • Whisper: —
  • Surprise %: -318.0%
Aug 01, 2024
Jun 30, 2024 (Pre market)
-0.09 Surprise
  • Reported EPS: $-1.69
  • Estimate: $-1.60
  • Whisper: —
  • Surprise %: -5.6%
May 02, 2024
Mar 31, 2024 (Pre market)
0.2 Surprise
  • Reported EPS: $-1.45
  • Estimate: $-1.65
  • Whisper: —
  • Surprise %: 12.1%
Feb 15, 2024
Dec 31, 2023 (Pre market)
-0.07 Surprise
  • Reported EPS: $-1.72
  • Estimate: $-1.65
  • Whisper: —
  • Surprise %: -4.2%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $-1.64
  • Estimate: $-1.70
  • Whisper: —
  • Surprise %: 3.5%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $-1.51
  • Estimate: $-1.56
  • Whisper: —
  • Surprise %: 3.2%
May 04, 2023
Mar 31, 2023 (Pre market)
0.23 Surprise
  • Reported EPS: $-1.47
  • Estimate: $-1.70
  • Whisper: —
  • Surprise %: 13.5%

Financials